01 2Gowling Lafleur Henderson LLP
02 18Gowling WLG (Canada) LLP
01 11336826
02 12149329
03 32340091
04 22350058
05 32350064
06 12372603
07 32378574
08 12627886
09 12635352
10 22771571
11 12783210
12 12904259
01 9RITUXIMAB
02 11Rituximab
01 9SOLUTION
02 11Solution
01 12012-08-29
02 12013-11-12
03 12018-06-12
04 32019-08-11
05 52019-11-09
06 22020-05-04
07 32020-08-02
08 22026-11-14
09 22030-09-10
Patent Expiration Date : 2012-08-29
Date Granted : 1995-08-29
Brand Name : RITUXAN
Patent Number : 1336826
Filing Date : 1988-01-07
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-08-29
Date Granted : 1995-08-29
Patent Expiration Date : 2013-11-12
Date Granted : 2008-07-15
Brand Name : RITUXAN
Patent Number : 2149329
Filing Date : 1993-11-12
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-11-12
Date Granted : 2008-07-15
Patent Expiration Date : 2019-11-09
Date Granted : 2012-05-08
Brand Name : RITUXAN
Patent Number : 2350064
Filing Date : 1999-11-09
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-11-09
Date Granted : 2012-05-08
Patent Expiration Date : 2019-08-11
Date Granted : 2013-02-05
Brand Name : RITUXAN
Patent Number : 2340091
Filing Date : 1999-08-11
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-08-11
Date Granted : 2013-02-05
Patent Expiration Date : 2018-06-12
Date Granted : 2012-09-11
Brand Name : RITUXAN
Patent Number : 2635352
Filing Date : 1998-06-12
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2018-06-12
Date Granted : 2012-09-11
Patent Expiration Date : 2020-08-02
Date Granted : 2012-01-03
Brand Name : RITUXAN
Patent Number : 2378574
Filing Date : 2000-08-02
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-08-02
Date Granted : 2012-01-03
Patent Expiration Date : 2019-11-09
Date Granted : 2015-10-13
Brand Name : RITUXAN
Patent Number : 2350058
Filing Date : 1999-11-09
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-11-09
Date Granted : 2015-10-13
Patent Expiration Date : 2020-05-04
Date Granted : 2016-11-15
Brand Name : RITUXAN
Patent Number : 2904259
Filing Date : 2000-05-04
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-05-04
Date Granted : 2016-11-15
Patent Expiration Date : 2020-05-04
Date Granted : 2015-11-17
Brand Name : RITUXAN
Patent Number : 2372603
Filing Date : 2000-05-04
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-05-04
Date Granted : 2015-11-17
Patent Expiration Date : 2026-11-14
Date Granted : 2016-10-04
Brand Name : RITUXAN
Patent Number : 2783210
Filing Date : 2006-11-14
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2026-11-14
Date Granted : 2016-10-04
